Literature DB >> 25560145

Committee opinion no. 620: Salpingectomy for ovarian cancer prevention.

.   

Abstract

Ovarian cancer has the highest mortality rate out of all types of gynecologic cancer and is the fifth leading cause of cancer deaths among women. Current attempts at screening for ovarian cancer have been unsuccessful and are associated with false-positive test results that lead to unnecessary surgery and surgical complications. Prophylactic salpingectomy may offer clinicians the opportunity to prevent ovarian cancer in their patients. Randomized controlled trials are needed to support the validity of this approach to reduce the incidence of ovarian cancer. The approach to hysterectomy or sterilization should not be influenced by the theoretical benefit of salpingectomy. Surgeons should continue to observe and practice minimally invasive techniques.

Entities:  

Mesh:

Year:  2015        PMID: 25560145     DOI: 10.1097/01.AOG.0000459871.88564.09

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  39 in total

1.  The Fallopian Tube in the 21st Century: When, Why, and How to Consider Removal.

Authors:  Roberta Venturella; Michele Morelli; Fulvio Zullo
Journal:  Oncologist       Date:  2015-09-17

2.  Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.

Authors:  Akila Subramaniam; Christina T Blanchard; Britt K Erickson; Jeff Szychowski; Charles A Leath; Joseph R Biggio; Warner K Huh
Journal:  Obstet Gynecol       Date:  2018-07       Impact factor: 7.661

3.  Feasibility of prophylactic salpingectomy during vaginal hysterectomy.

Authors:  Danielle D Antosh; Rachel High; Heidi W Brown; Sallie S Oliphant; Husam Abed; Nisha Philip; Cara L Grimes
Journal:  Am J Obstet Gynecol       Date:  2017-07-20       Impact factor: 8.661

4.  Adnexectomy at the time of vaginal hysterectomy for pelvic organ prolapse.

Authors:  Emily A Slopnick; David D Sheyn; Graham C Chapman; Sangeeta T Mahajan; Sharif El-Nashar; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2019-05-21       Impact factor: 2.894

5.  Women's preferences for permanent contraception method and willingness to be randomized for a hypothetical trial.

Authors:  Adriana Piazza; Kelly Schwirian; Fiona Scott; Machelle D Wilson; Nikki B Zite; Mitchell D Creinin
Journal:  Contraception       Date:  2018-09-26       Impact factor: 3.375

6.  Size matters in planning hysterectomy approach.

Authors:  Yasmina Mohan; Vicki Y Chiu; Neal M Lonky
Journal:  Womens Health (Lond)       Date:  2016-07

7.  Fallopian Tube Ligation or Salpingectomy as Means for Reducing Risk of Ovarian Cancer.

Authors:  J Brian Szender; Shashikant B Lele
Journal:  AMA J Ethics       Date:  2015-09-01

8.  Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries.

Authors:  Britton Trabert; Sally B Coburn; Andrea Mariani; Hannah P Yang; Philip S Rosenberg; Gretchen L Gierach; Nicolas Wentzensen; Kathy A Cronin; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

9.  The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.

Authors:  Akila Subramaniam; Brett D Einerson; Christina T Blanchard; Britt K Erickson; Jeff Szychowski; Charles A Leath; Joseph R Biggio; Warner K Huh
Journal:  Gynecol Oncol       Date:  2018-11-23       Impact factor: 5.482

Review 10.  Update on permanent contraception options for women.

Authors:  Eva Patil; Jeffrey T Jensen
Journal:  Curr Opin Obstet Gynecol       Date:  2015-12       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.